Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital rehab could bring heart recovery to your living room

NCT ID NCT06759805

Disease control Sponsor: Haukeland University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 12-week home-based digital program called eCardiacRehab for people who have had a heart procedure (PCI). The program includes video messages, modules, and tracking to support recovery. Researchers want to see if patients will use it regularly and find it acceptable. The goal is to make cardiac rehabilitation more accessible, especially for older adults, women, and those with other health issues.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
home-based digital cardiac rehabilitation program
What this could lead to
If successful, this could provide an effective, accessible alternative to traditional center-based cardiac rehab, helping more patients recover at home.
What could go wrong
This is a small feasibility study (80 participants) focused on engagement and adherence, not yet testing health outcomes. The digital format may not suit all patients, and results may not generalize beyond Norway.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Oct 2035

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number, * With coronary artery disease after percutaneous coronary intervention * Are living at home and have internet available to them * Providing signed informed consent Exclusion Criteria: * Patients with cognitive impairment that may interfere with the ability to comply with the study protocol * Severe aortic stenosis * Severe arrhythmias * Expected lifetime less than one year as determined by study personnel * Otherwise clinically unstable * Not fully revascularized (awaits percutaneous coronary intervention or coronary artery bypass graft surgery) * Inability to comply with the study protocol due to any physical disability, somatic disease, or mental problems as determined by study personnel

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder hypertensive disorder Medication Adherence Motor Activity Psychological Well-Being Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, medication Adherence, treatment Cardiac rehabilitation Comorbidities Continuity of patient care Coronary artery disease Cost-benefit analysis Ehealth literacy ETHICS Health literacy Hypertension Mental health Older adults (65 years and older) Physical activity Secondary prevention of coronary heart disease Women

Contacts and locations

Locations

  • Haukeland University Hospital

    Bergen, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.